"","Num","POD","SD","%","Genes","KE"
"GO:0046903","1","1.2000029",NA,"0.43","554998","SUPPRESSION VLDL SECRETION; INCREASE MUCIN PRODUCTION; INCREASED SECRETION OF LOCAL GROWTH FACTORS"
"GO:0004872","1","1.51397562",NA,"0.42","557500","ACTIVATION PXR/SXR"
"GO:0030154","1","1.51397562",NA,"1.54","557500","DIFFERENTIATION OF MYOFIBROBLAST"
"GO:0006898","1","1.72722368",NA,"2.63","386590","REDUCTION VITELLOGENIN ACCUMULATION INTO OOCYTES AND OOCYTE GROWTH/DEVELOPMENT; INCREASED LDL UPTAKE"
"GO:0007568","1","2.09103976",NA,"1.16","793907","ACCELERATED AGING"
"GO:0009611","1","2.09103976",NA,"0.89","793907","ACCUMULATION DAMAGED MITOCHONDRIAL DNA"
"GO:0042060","1","2.09103976",NA,"1.14","793907","FAILURE IN VASCULAR REPAIR MECHANISMS UNRESOLVED BLOOD LOSS HEMORRHAGE"
"ARYL HYDROCARBON RECEPTOR PATHWAY","1","2.09103976",NA,"2.08","793907","UP REGULATION CYP1A1; ACTIVATION AHR"
"CTOME FOXO MEDIATED TRANSCRIPTION","1","2.09103976",NA,"3.57","793907","ACTIVATION FOXO"
"GO:0005102","4","6.31748076266012","0.150836636544255","1.92","793907, 386590, 30265, 30265","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS"
"GO:0005488","7","6.53189982779872","0.0871136289330521","0.65","798920, 793907, 557500, 386590, 30265, 30265, 30071","INCREASED BINDING OF CHEMICALS TO 2U SERUM"
"GO:0030163","3","9.13281107833794","0.208785991514798","1.96","386590, 30265, 30265","INCREASED CATABOLISM OF MUSCLE PROTEIN"
"REGULATION OF CELL DEATH","3","9.13281107833794","0.208785991514798","1.12","386590, 30265, 30265","N/A CELL INJURY/DEATH"
"REGULATION OF WNT SIGNALING PATHWAY","3","9.73364963533434","0.192809996098395","3.8","793907, 30265, 30265","INHIBITION WNT PATHWAY"
"GO:0000003","2","21.00063463","0","0.99","30265, 30265","REDUCED REPRODUCTIVE SUCCESS; REPRODUCTIVE FAILURE"
"GO:0001775","2","21.00063463","0","1.02","30265, 30265","ACTIVATION DENDRITIC CELLS"
"GO:0001816","2","21.00063463","0","1.67","30265, 30265","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION; PRODUCTION OF NERVE GROWTH FACTOR  EPITHELIAL IRRITATION; NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION"
"GO:0003158","2","21.00063463","0","8.33","30265, 30265","IMPAIRMENT ENDOTHELIAL NETWORK"
"GO:0004882","2","21.00063463","0","5.71","30265, 30265","N/A ANDROGEN RECEPTOR ANTAGONISM; AGONISM ANDROGEN RECEPTOR; DECREASED ANDROGEN RECEPTOR ACTIVITY; ACTIVATION ANDROGEN RECEPTOR"
"GO:0007059","2","21.00063463","0","4.55","30265, 30265","INCREASED CHROMOSOME MISSEGGREGATION"
"GO:0007249","2","21.00063463","0","4.65","30265, 30265","INHIBITION NUCLEAR FACTOR KAPPA B NF-KB"
"GO:0010463","2","21.00063463","0","16.67","30265, 30265","INCREASED PROLIFERATION OF MESENCHYMAL CELLS"
"GO:0016055","2","21.00063463","0","8.7","30265, 30265","ALTERATION WNT PATHWAY"
"GO:0019904","2","21.00063463","0","1.63","30265, 30265","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS"
"GO:0030331","2","21.00063463","0","22.22","30265, 30265","INCREASED ER BINDING TO DNA CLASSICAL PATHWAY; INCREASED ER BINDING TO TF TO DNA NON-CLASSICAL PATHWAY"
"GO:0036475","2","21.00063463","0","40","30265, 30265","N/A NEURONAL DYSFUNCTION"
"GO:0044703","2","21.00063463","0","1.72","30265, 30265","N/A REPRODUCTIVE FAILURE"
"GO:0048469","2","21.00063463","0","8.33","30265, 30265","INCREASED OOCYTE MATURATION"
"GO:0050673","2","21.00063463","0","2.44","30265, 30265","INCREASE REGENERATIVE CELL PROLIFERATION TUBULAR EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION TERMINAL BRONCHIOLAR EPITHELIAL CELLS"
"GO:0099536","2","21.00063463","0","1.8","30265, 30265","DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN; DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN"
"BREAST CANCER PATHWAY","2","21.00063463","0","1.75","30265, 30265","N/A BREAST CANCER"
"ENDOMETRIAL CANCER","2","21.00063463","0","2.94","30265, 30265","INCREASE ENDOMETRIAL ADENOCARCINOMAS"
"NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA","2","21.00063463","0","4.17","30265, 30265","INCREASE HERITABLE MUTATIONS IN OFFSPRING"
"ABNORMAL LIVER MORPHOLOGY","2","21.00063463","0","1.68","30265, 30265","INDUCTION LIVER “DYSFUNCTIONAL” CHANGES BY CGA 330050; INFLAMMATION LIVER; N/A LIVER FIBROSIS; INCREASE RBC CONGESTION IN LIVER; INCREASE LIVER AND SPLENIC HEMOSIDEROSIS; REDUCTION VITELLOGENIN SYNTHESIS IN LIVER; INCREASE VITELLOGENIN SYNTHESIS IN LIVER; FORMATION LIVER FIBROSIS; FORMATION LIVER TUMOR"
"ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES","2","21.00063463","0","0.5","30265, 30265","DAMAGING RED BLOOD CELLS; HEMOLYSIS"
"ABNORMALITY OF REPRODUCTIVE SYSTEM PHYSIOLOGY","2","21.00063463","0","1.94","30265, 30265","N/A IMPAIRMENT OF REPRODUCTIVE CAPACITY"
"ABNORMALITY OF THE ABDOMINAL ORGANS","2","21.00063463","0","1.18","30265, 30265","IMPAIRED DEVELOPMENT OF REPRODUCTIVE ORGANS"
"ABNORMALITY OF THE LIVER","2","21.00063463","0","0.27","30265, 30265","INCREASED INDUCTION OF UDPGT'S IN LIVER; INCREASED LIVER STEATOSIS; INCREASED LIVER STEATOSIS; N/A HEPATOTOXICITY HEPATOPATHY INCLUDING A CONSTELLATION OF OBSERVABLE EFFECTS; INDUCTION SUSTAINED HEPATOTOXICITY"
"ABNORMALITY OF THE OVARY","2","21.00063463","0","3.51","30265, 30265","REDUCED PROSTAGLANDINS OVARY"
"ABNORMALITY OF THE PITUITARY GLAND","2","21.00063463","0","4.17","30265, 30265","INCREASED ADENOMAS PITUITARY"
"HEPATOCELLULAR CARCINOMA","2","21.00063463","0","15.38","30265, 30265","FORMATION HEPATOCELLULAR AND BILE DUCT TUMORS; INCREASE ADENOMAS/CARCINOMAS HEPATOCELLULAR; TUMORIGENESIS HEPATOCELLULAR CARCINOMA"
"INCREASED CIRCULATING PROLACTIN CONCENTRATION","2","21.00063463","0","40","30265, 30265","INCREASED PROLACTIN SECRETION; INCREASED PROLACTIN EXPOSURE"
"INCREASED SUSCEPTIBILITY TO FRACTURES","2","21.00063463","0","5.71","30265, 30265","INCREASED DISEASE SUSCEPTIBILITY"
"NEOPLASM OF THE SKIN","2","21.00063463","0","6.06","30265, 30265","SENSITISATION SKIN"
"SOMATIC MUTATION","2","21.00063463","0","2.38","30265, 30265","INCREASED INDUCED MUTATIONS IN CRITICAL GENES; INCREASE MUTATIONS; INCREASE MUTATIONS IN CRITICAL GENES"
"TISSUE ISCHEMIA","2","21.00063463","0","13.33","30265, 30265","OCCURRENCE RENAL ISCHEMIA"
"PEPTIDYL LYSINE MODIFICATION","2","21.00063463","0","2.82","30265, 30265","N/A COVALENT BINDING TO PROTEIN POSSIBLY LYSINE RESIDUE"
"POSITIVE REGULATION OF GENE EXPRESSION","2","21.00063463","0","1.1","30265, 30265","ALTERED GENE EXPRESSION"
"SMOOTH MUSCLE CELL PROLIFERATION","2","21.00063463","0","7.69","30265, 30265","HYPERTROPHY/HYPERPLASIA SMOOTH MUSCLE"
"UPPER MOTOR NEURON DYSFUNCTION","2","21.00063463","0","0.42","30265, 30265","DECREASE HISTAMINERGIC NEURON EXCITATION; OCCURRENCE CYTOPLASMIC VACUOLIZATION BILE DUCT CELL; OCCURRENCE CYTOPLASMIC VACUOLIZATION KUPFFER CELL"
"ABNORMALITY OF ADRENAL PHYSIOLOGY","2","21.00063463","0","2.17","30265, 30265","INCREASE RENAL PATHOLOGY DUE TO VTG DEPOSITION; DECREASED RENAL ABILITY TO DILUTE URINE; OCCURRENCE KIDNEY TOXICITY; INCREASED KIDNEY FAILURE"
"ABNORMAL NASAL MORPHOLOGY","2","21.00063463","0","1.29","30265, 30265","INCREASE SITE OF CONTACT NASAL TUMORS"
"RESPONSE TO ESTRADIOL","2","21.00063463","0","6.67","30265, 30265","REDUCTION PLASMA 17BETA-ESTRADIOL CONCENTRATIONS"
"GO:0005515","3","27.1946264680478","0.0648079596311832","6.38","30265, 30265, 30071","BINDING SH-/SELEN-PROTEINS; COVALENT BINDING PROTEIN"
"GO:0009790","3","27.1946264680478","0.0648079596311832","1.78","30265, 30265, 30071","DEFECT OF EMBRYOGENESIS"
"GO:0040011","3","27.1946264680478","0.0648079596311832","1.32","30265, 30265, 30071","INCREASED LOCOMOTION; INCREASED MUSCULAR WAVES IN FOOT; DECREASED LOCOMOTION"
"GO:0048870","3","27.1946264680478","0.0648079596311832","1.5","30265, 30265, 30071","INCREASED MOTILITY"
"GO:0072358","3","27.1946264680478","0.0648079596311832","2.7","30265, 30265, 30071","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION"
"HEART DEVELOPMENT","3","27.1946264680478","0.0648079596311832","2.38","30265, 30265, 30071","ALTERED LARVAL DEVELOPMENT; IMPAIRED DEVELOPMENT"
"ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY","1","45.60205936",NA,"0.68","30071","INCREASED RESPIRATORY DISTRESS/ARREST"
"ABNORMAL LUNG MORPHOLOGY","1","45.60205936",NA,"0.78","30071","INCREASE ADENOMAS/CARCINOMAS BRONCHIOLOALVEOLAR"
